Switch theme
Sign up to access all valuation multiples
Ain Holdings Inc's core business is the dispensing pharmacy business that includes preparing and dispensing drugs based on prescriptions. The company also generates revenue by selling generic drugs wholesale, pharmacy staffing services, and pharmacy consulting services. The company’s additional business activity includes both urban and suburban drug and cosmetic stores. Ain operates the ainz & tuple brand that specifically targets female consumers in urban areas. The company also executes small real estate rental strategies.
1969
9.8K+
LTM Revenue $3.2B
LTM EBITDA $226M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
AiN Group has a last 12-month revenue (LTM) of $3.2B and a last 12-month EBITDA of $226M.
In the most recent fiscal year, AiN Group achieved revenue of $2.7B and an EBITDA of $206M.
AiN Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See AiN Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.2B | XXX | $2.7B | XXX | XXX | XXX |
| Gross Profit | $3.2B | XXX | $408M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 15% | XXX | XXX | XXX |
| EBITDA | $226M | XXX | $206M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 8% | XXX | XXX | XXX |
| EBIT | $134M | XXX | $140M | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $72.9M | XXX | $78.2M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, AiN Group's stock price is JPY 5642 (or $39).
AiN Group has current market cap of JPY 198B (or $1.4B), and EV of JPY 205B (or $1.4B).
See AiN Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.4B | $1.4B | XXX | XXX | XXX | XXX | $2.08 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, AiN Group has market cap of $1.4B and EV of $1.4B.
AiN Group's trades at 0.5x EV/Revenue multiple, and 6.5x EV/EBITDA.
Equity research analysts estimate AiN Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AiN Group has a P/E ratio of 18.6x.
See valuation multiples for AiN Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | 6.2x | XXX | 6.5x | XXX | XXX | XXX |
| EV/EBIT | 10.5x | XXX | 10.4x | XXX | XXX | XXX |
| EV/Gross Profit | 0.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.6x | XXX | 18.3x | XXX | XXX | XXX |
| EV/FCF | -5.1x | XXX | -7.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAiN Group's last 12 month revenue growth is 10%
AiN Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $27K for the same period.
AiN Group's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AiN Group's rule of X is 31% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for AiN Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 11% | XXX | XXX | XXX |
| Rule of 40 | 17% | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 31% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $27K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AiN Group acquired XXX companies to date.
Last acquisition by AiN Group was XXXXXXXX, XXXXX XXXXX XXXXXX . AiN Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was AiN Group founded? | AiN Group was founded in 1969. |
| Where is AiN Group headquartered? | AiN Group is headquartered in Japan. |
| How many employees does AiN Group have? | As of today, AiN Group has 9.8K+ employees. |
| Is AiN Group publicy listed? | Yes, AiN Group is a public company listed on TKS. |
| What is the stock symbol of AiN Group? | AiN Group trades under 9627 ticker. |
| When did AiN Group go public? | AiN Group went public in 2009. |
| Who are competitors of AiN Group? | Similar companies to AiN Group include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of AiN Group? | AiN Group's current market cap is $1.4B |
| What is the current revenue of AiN Group? | AiN Group's last 12 months revenue is $3.2B. |
| What is the current revenue growth of AiN Group? | AiN Group revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of AiN Group? | Current revenue multiple of AiN Group is 0.4x. |
| Is AiN Group profitable? | Yes, AiN Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of AiN Group? | AiN Group's last 12 months EBITDA is $226M. |
| What is AiN Group's EBITDA margin? | AiN Group's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of AiN Group? | Current EBITDA multiple of AiN Group is 6.2x. |
| What is the current FCF of AiN Group? | AiN Group's last 12 months FCF is -$275M. |
| What is AiN Group's FCF margin? | AiN Group's last 12 months FCF margin is -9%. |
| What is the current EV/FCF multiple of AiN Group? | Current FCF multiple of AiN Group is -5.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
